Acuren Corporation
TIC
$12.11
$0.110.92%
Weiss Ratings | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Reward Grade | U | |||
Rating Factors | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Unrated | |||
Growth Index | Unrated | |||
Efficiency Index | Unrated | |||
Solvency Index | Unrated | |||
Total Return Index | Unrated | |||
Volatility Index | Unrated | |||
Beta / Standard Deviation | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Price History | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -6.70% | |||
30-Day Total Return | 3.06% | |||
60-Day Total Return | -- | |||
90-Day Total Return | -- | |||
Year to Date Total Return | -2.59% | |||
1-Year Total Return | -- | |||
2-Year Total Return | -- | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -15.20% | |||
52-Week Low % Change | 19.90% | |||
Price | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $14.28 | |||
52-Week Low Price | $10.10 | |||
52-Week Low Price (Date) | Jan 03, 2025 | |||
52-Week High Price (Date) | Feb 20, 2025 | |||
Valuation | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 1.47B | |||
Enterprise Value | 2.15B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -5.23 | |||
Earnings Per Share Growth | -427.39% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.93 | |||
Price/Book (Q) | 1.21 | |||
Enterprise Value/Revenue (TTM) | 1.94 | |||
Price | $12.11 | |||
Enterprise Value/EBITDA (TTM) | 24.87 | |||
Enterprise Value/EBIT | -618.06 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 85.31M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | 0.00% | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 800-218-7450 | |||
Address | 14434 Medical Complex Drive Tomball, TX 77377 | |||
Website | www.acuren.com | |||
Country | United States | |||
Year Founded | 1991 | |||
Profitability | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -0.31% | |||
Profit Margin | -9.68% | |||
Management Effectiveness | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 1.11B | |||
Total Revenue (TTM) | 1.11B | |||
Revenue Per Share | $12.96 | |||
Gross Profit (TTM) | 270.12M | |||
EBITDA (TTM) | 86.40M | |||
EBIT (TTM) | -3.48M | |||
Net Income (TTM) | -107.08M | |||
Net Income Avl. to Common (TTM) | -107.08M | |||
Total Revenue Growth (Q YOY) | 14.11% | |||
Earnings Growth (Q YOY) | -8,536.25% | |||
EPS Diluted (TTM) | -5.23 | |||
EPS Diluted Growth (Q YOY) | -610.76% | |||
Balance Sheet | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 132.46M | |||
Cash Per Share (Q) | $1.55 | |||
Total Current Assets (Q) | 426.71M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.21B | |||
Current Ratio (Q) | 3.623 | |||
Book Value Per Share (Q) | $9.98 | |||
Total Assets (Q) | 2.33B | |||
Total Current Liabilities (Q) | 117.79M | |||
Total Debt (Q) | 810.38M | |||
Total Liabilities (Q) | 1.12B | |||
Total Common Equity (Q) | 1.21B | |||
Cash Flow | TIC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -1.90B | |||
Cash from Financing (TTM) | 1.42B | |||
Net Change in Cash (TTM) | -409.18M | |||
Levered Free Cash Flow (TTM) | 77.34M | |||
Cash from Operations (TTM) | 64.96M | |||